DOXAZOSIN
- Product NDC
- 72189-117
- 11-digit product format
- 721890117
- Labeler code
- 72189
- Product ID
- 72189-117_2be8ef13-7e70-fc50-e063-6394a90a0f27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOXAZOSIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- direct rx
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2020-12-02
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOXAZOSIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-117-60 | DOXAZOSIN | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-117 | DOXAZOSIN TABLET [DIRECT RX] | 2 | Current NDC, Legacy NDC, 1 package rows | 20250119_b57cf33b-e0bd-54e9-e053-2a95a90a5a6a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-117-60 | 72189011760 | 60 TABLET in 1 BOTTLE (72189-117-60) | 60 tablet | 2020-12-02 | 0000-00-00 | No | No | Current |